Familial combined hyperlipidemia (FCH) is char acterized by a familial occurrence of a multiple-type hyperlipid emia, associated with coronary risk. The latter may be related to increased levels of small, dense LDL particles that have been found to be more prone to oxidative modification. We isolated total LDL as fresh as possible from 12 normolipidemic relatives with a buoyant LDL subfraction profile (group 1), 7 normolip idemic subjects with a dense LDL subtraction profile (group 2), and 16 hyperlipidemie FCH subjects with a dense LDL subfrac tion profile (group 3). In these nonobese and normotensive men, we studied the resistance of total LDL against C u2+-oxidation in vitro. In addition, we analyzed the a-tocopherol and the coen zyme Q10 contents of LDL and determined their relation to LDL oxidizability. LDL isolated from group 3 subjects was more sus ceptible to oxidative modification than LDL from group 1 sub jects (lag time: 60.4±8.1 versus 70.4± 11.4 minutes; P<.{)5). For the combined groups, the ratio of ubiquinol-10 to polyunsaturated fatty acids in LDL, together with the basal amount of dienes in LDL, were good predictors of the rale of LDL oxidation (/i'=.73, P=.00()I). In groups 2 and 3, the redox status of coenzyme Q10 (ubiquinol-10/ubiquinone-10) and the ratio of ubiquinol-10 to a-tocopherol in LDL were reduced compared with group 1 (ƒ*<.()5). The K-value, a measure of the LDL density, correlated with the the redox status (r=.37, P<A)5). We conclude that in subjects with FCH total LDL is more prone to oxidation, due to the predominance of dense LDL particles. In addition, the de creased redox status of coenzyme Q 10 in LDL from subjects with a dense LDL subfraction profile suggests that the LDL in the circulation has already undergone some oxidation. (Arterioscler Thro mb Vase Biol.
amilial combined (FCH), identified by Goldstein et a l,1 is a genetically and metabolically heterogeneous common lipid disorder, associated with an increased risk for cardio vascular disease. '-2 The trait is characterized by a mul tiple-type hyperlipidemia in iirst-degree relatives. Af fected persons exhibit elevated plasma concentrations of cholesterol or triglycerides, or both. In addition, el evated concentrations of apolipoprotein B and reduced concentrations of HDL-C are observed. Furthermore, FCH has been shown to be associated with a predom inance of dense LDL subfniction profiles.M Small, dense LDL was generally found to be prevalent in pa tients with coronary heart disease.5 1 (1 Studies on LDL oxidation revealed that small, dense LDL particles are more prone to oxidative modification than buoyant LDL.1112 Oxidation of LDL is believed to play an important role in early atherosclerosis.1 1 ' After being oxidatively modified in the intima, LDL is probably taken up by scavenger receptors of macrophages.14 As a result of uncontrolled uptake of oxidized LDL, macro phages are converted into cholesterol-rich foam cells, a hallmark of early atherosclerotic lesions. 15 Evidence in humans to support the oxidation hypothesis has been pro vided by studies that showed an association between plasma autoantibodies against oxidatively modified LDL and the progression of cardiovascular disease.1 17 Epi topes of oxidized LDL also were detected in human fatty streaks. According to the oxidation hypothesis, LDL is pro tected against oxidative stress by antioxidants, thereby delaying the formation of modified LDL. The lipophilic antioxidants cv-TOH, QHU-10, /3-carotene, and lyeopene are present in LDL.2H Epidemiological studies suggested that high (>100 mg/d) cv-TOI 1 intake contributes to re duced risk of atherosclerosis.21-'2 Although a-TOH is believed to be the major antioxidant in responsible for the protection against oxidation in vivo,20 extensive work by Stocker and co-workers (reviewed in Reference 23) suggests that the determination of the LDL QHU-IO con tent is more relevant to assess the initial state of LDL peroxidation in vivo. QHU-10 (or reduced coenzyme Q) is an endogenous product of the mevanolate pathway, having coenzymatic activity in the enzyme system of mi tochondria, where it functions as an essential electron car rier in the respiratory system.2 ,1 This antioxidant also is present in foods such as soybeans, walnuts, almonds, oils, fruits, and spinach.25 Despite low concentrations in LDL (0.5 to 0.8 mol/LDL particle), compared with LDL Selected Abbreviations and Acronyms a-TOH = a-tocopherol BHT FCH HDL-C HPLC LDL-C PUFA butylated hydroxytoluene familial combined hyperlipidemia (4) HDL cholesterol high-performance liquid chromatography LDL cholesterol polyunsaturated fatty acids; sum of C18:2 and C20:4 Q10 = ubiquinone-10 QHr 10 VLDL-C ubiquinol-10 VLDL cholesterol VLDL-TG = VLDL triglycerides a-TOH content (8 to 15 mol/LDL particle), QH2-10 has shown itself to be the first-line defense against oxidative stress in LDL. 26 In volunteers, a long-term supplemen tation with Q10 resulted in a twofold increase in the plasma concentration of QH2-10.27 This was accompa nied by increased resistance of LDL against oxidation, initiated by aqueous peroxyl radicals, in vitro. 27 Besides the contribution of antioxidants, LDL oxidizability in vi tro was found to be influenced by the fatty acid compo sition28 and the chemical composition of LDL.11
Although a specific marker to definitively ascertain the diagnosis of FCH is still lacking, a recent study shows that a predominance of small, dense LDL particles is characteristic for affected FCH relatives,4 especially when accompanied by hyperlipidemia. Regarding the ob servations on the relative constancy of the LDL subfrac tion profile in relation to that of plasma lipid concentra tions, especially that of plasma triglycerides (S.J.H. Bredie, P.N.M. Demacker, A.F.H. Stalenhoef, unpub lished observations, 1995), we assume that the presence of dense LDL is a helpful metabolic marker for identi fying affected relatives of FCH kindreds characterized by variability in plasma concentrations of lipids and choles terol. Therefore, FCH families offer a unique opportunity to investigate the oxidation characteristics of both dense LDL from subjects with or without hyperlipidemia and buoyant LDL from normolipidemic subjects, all present in these families.
Methods
Chemicals Q10, D,L-a-TOI-I, and BHT were from Sigma Chemical Co; Q10 was reduced to QHi-10, essentially as described by Frei et al. 29 All reagents and HPLC solvents were of high analytical grade.
Subject Selection
All participants were selected from 40 well-defined FCH fam ilies, consisting of both affected and nonaffected relatives.4 Di agnosis of FCH was based on the following criteria: (1) the pres ence in first-degree relatives of a multiple-type hyperlipidemia with elevated levels of total plasma cholesteiol and/or triglycer ides using the age-and sex-related 90th percentile upper levels of the prospective cardiovascular Münster (PROCAM) study30 and (2) a family history of premature cardiovascular disease be fore age 60. Families were excluded when first-degree family members had tendon xanthomata. None of the probands was ho mozygous for the apo E2 allele, and for all probands, a secondary cause (eg, diabetes mellitus, hypothyroidism, and hepatic or renal impairment) of the presence of the hyperlipidemia could be ex cluded by standard laboratory tests.
On the basis of the density of the LDL subfraction profiles and plasma lipid concentrations, 35 subjects from 13 families were selected to participate in this study. Twelve subjects were characterized by a buoyant LDL subfraction profile and 23 subjects by a dense LDL subfraction profile. The method of LDL subfractionation is described elsewhere in this article. All subjects with a buoyant LDL subfraction profile had nor mal lipids. Of the subjects with a dense LDL subfraction pro file, 7 subjects were normolipidemic and 16 subjects were hyperlipidemic. This resulted in three groups of subjects; basal characteristics are summarized in Table 1 . None of the sub jects were on drug treatment or on a special diet, and none of the subjects used vitamin supplements.
Plasma M easurements
Fasting blood samples were collected into evacuated tubes containing K3-EDTA (1 mg/mL). The tubes were immediately placed on ice in the dark. Thirty nonlocal participants were visited at their homes. At 2 hours after blood sampling, plasma was separated from blood cells by centrifugation at 3600 rpm for 8 minutes at 4°C. Prior to the measurement of a-TOH and QH2-10 concentrations in plasma, saccharose as cryopreservative (final concentration 6 mg/mL) and BI-IT as antioxidant (final concen tration 250 ¿/,g/mL) were added.
VLDL and IDL ( d s 1.019 g/mL) were isolated by ultracentri fugation. After removal of VLDL and IDL, cholesterol and tri glyceride levels were measured in the infranatant and in total plasma. HDL was isolated from whole plasma by the polyeth ylene glycol 6000 method.31 Cholesterol and triglyceride levels were determined by enzymatic methods (No. 237574, Boehringer-Mannheim; No. 6669, Sera Pak, Miles, respectively). LDL cholesterol was calculated by subtraction.
Analysis of LDL Subfraction Profile
Each individual LDL subfraction profile was defined by a con tinuous variable, K, as described in detail by de Graaf et al. 32 Bi'iefly, LDL subfractions were separated by single-spin densitygradient ultracentrifugation, according to an earlier described method.33 After ultracentrifugation the LDL subfractions were visible as distinct bands in the middle of the tube. Up to five LDL subtractions could be distinguished. The tubes were photo graphed. Accurate documentation of the LDL subtraction distri bution was obtained by scanning the slides on an LKB 2202 ultrascan laser densitometer (Pharmacia LKB). 32 The relative peak heights of the LDL subfractions on the scans were used to calculate parameter K as a continuous variable, which best de scribes each individual LDL subfraction profile. A negative value (K<0) reflects a more dense subfraction profile and a positive K value (Ks:0) a more buoyant profile. 32 Oxidation of LDL Plasma isolation was immediately followed by LDL isola tion by density-gradient ultracentrifugation (40 000 rpm for 18 hours at 4°C) using an SW40 rotor (Beckman).34 After iso lation of total LDL, the protein content of LDL was measured by the method of Lowry et al, 35 with chloroform extraction to remove turbidity, using bovine serum albumin as a standard. The oxidation experiments were performed as described by Esterbauer et al36 as modified by Princen et al. 34 Briefly, the oxidation of LDL (60 ¡xg apolipoprotein/niL) was initiated by the addition of C u S 0 4 to a final concentration of 18 /imol/L at 37°C. The kinetics of the oxidation of LDL was determined by monitoring the change of the 234-nm diene absorption in a thermostatically monitored UV spectrophotometer (Lambda 12, Perkin Elmer GmbH), equipped with a nine-position au tomatic sample changer. Each LDL preparation was oxidized twice in two separate oxidation runs on the same day. Every oxidation run was controlled by analyzing one reference LDL, prepared from a pooled plasma stored at -80°C . The interas say coefficients of variation for the oxidation parameters lag time and oxidation rate, and maximal amount of conjugated dienes formed per milligram of protein of the reference LDL amounted to 1.2%, 5%, and 4.7%, respectively (n=I0). To 
Determination of a-T O H , Q H 2-10, and Q10 in Plasma and LD L
To exclude any oxidation of QH2-10, antioxidants were deter mined in material as fresh as possible. Consequently, plasma sep aration was immediately followed by LDL isolation by densitygradient ultracentrifugation (40 000 rpm for 18 hours at 4°C). LDL was isolated by cautious aspiration. Before extraction, BI-IT was added to the LDL preparations to a final concentration of 250 /ig/mL. The concentrations of Q-10 (oxidized form of co enzyme Q10) in plasma and LDL were determined by HPLC (Spectra Physics model 8800) with UV detection at 275 nm, se quentially followed by electrochemical detection (Decade, Antec) for the determination of a-TOH and QH-.-10.17 In each run, samples obtained of group 2 and/or group 3 subjects were blindly analyzed together with samples obtained of group 1 subjects. Deoxygenated and transition-metal-free aqueous solvents were used. All treatments were performed on ice, in the dark, and under nitrogen.
Immediately after isolation, plasma or LDL (200 ¡xL) was mixed with 2.0 mL ice-cold methanol. Subsequently, 4.0 mL icecold n-hexane was added and the mixture was vortex-mixed for 2 minutes. To exclude artifact due to instability, samples were extracted in series of maximal 10. Alter ceiUriftmation lor 2 W cminutes at 3600 rpm al 4°C, the hexane upper layer was collected and the extraction procedure was repeated. Both hexane layers were pooled and dried under a flow of nitrogen within 45 minutes at room temperature. The residue was stored al -20°C until in jection within 4 hours. Just before injection onto the HPLC col umn, the residue was dissolved in the mobile phase, consisting of 22.5% (vol/vol) methanol and 77.5% (vol/vol) ethanol/isopropanol (95:5) with 20 mmol/L lithiumperehlorate as electrolyte. Twenty microliters of sample was injected onto an Inertsil ODS-2 column (200X3.0 mm; 5-//m particle size) equipped with a reverse-phase guard column (10x2 mm) (both from Chrompack). a-TOH and QI-L-IO were eluted isocratically with the mo bile phase at a How rate of 0.35 mL/min. The eluate was moni tored with an electrochemical detector, A VT-03 How cell with GC working electrode (Antee) was used. The applied potential was 600 mV (versus Ag/AgCl in saturated LiCl). The interassay coefficients of variation for the determination of plasma and LDL concentrations of cv-TOH were 1.3% and 4.5% (n=6), respee-tively; of Q H j-10, 5.9% and 4.4% (n=8), respectively; of Q10, 3.1% and 5.6% (n=8), respectively.
Stability of Q H 2-10
Because of the suggested instability of QHj-10 in plasma and especially in LDL,2< ,-1K we performed stability experiments to val idate our results. In whole blood, QI-L-IO was found to be stable for at least 4 hours in the dark at 4°C (99.6±3.1% to initial con centrations; n=6). QH2-10 concentrations in plasma were stable during storage in the presence of 250 fig BHT/mL for up to I week at -80°C (98.0±3.0% to initial concentrations; n=3). To use similar LDL preparations for both the oxidation and antiox idant experiments, we isolated LDL by density-gradient ultracen trifugation in the absence of BUT. Q H j-10 concentrations in LDL were 104.1 ±4.6% (n=8) compared with those concentrations measured in LDL isolated in the presence of BHT. Prior to all extractions we added 250 ¿/g BHT/mL. QHr 10 concentrations in LDL, however, were s without BHT (99.0±2.1 % |n=3] versus BHT method). Until hex ane extraction of the LDL preparations, LDL was stored in 2 mL of methanol at -20°C after mixing. Under these conditions, QH2-10 was found to be stable for at least 24 hours (100.4±3.8% of initial concentrations; n -6 ). Consequently, Q10 concentrations during the described storage conditions were stable. After the lipid extraction, the combined hexane layers were evaporated un der N-i(g) and residues were stored at -20°C until analysis within 4 hours. During this time, Q H r 10 concentrations were stable (98.0±2.0% of initial concentrations; n=6). However, storage of the lipid residues for 24 hours at -20°C resulted in a 43.5±8.7% loss of the QHr 10 content. Consequently, the Q 10 content was ar to at extraction increar1 '
Determ ination of Fatty Acids in LDL
The concentrations of polyunsaturated (C l8:2; C20:4) and of monounsaturated (C l8:1) fatty acids in LDL were essentially as described in detail by tie Graaf et al."
Prior to statistical testing, plasma triglycerides and VLDL-TG were transformed logarithmically because of skewing of the dis tributions. Differences in smoking and personal history of coro nary artery disease were calculated by a x z test. A one-way ANOVA was used to analyze the differences in the studied pa rameters between the three groups, followed by additional Tukey's multiple comparison tests. All values are presented as mean±SD. Associations between variables were calculated with Pearson's correlation coefficients. All statistical analyses, includ ing logistic regression analysis, were performed using SPSS/PC software (SPSS Inc). Vnl 17 
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Results
Plasm a Lipids, Lipoproteins, and K Values Mean concentrations of plasma lipids and lipoproteins and the characterization of the LDL subfraction profiles of the respective groups are presented in Table 1 . The per sonal history of coronary heart disease increased from 0% to 31% in groups 1 to 3, respectively. Compared with groups 1 and 2, group 3 subjects had, by selection, higher concentrations of total cholesterol, LDL-C, VLDL-C, total triglycerides, and VLDL-TG, lower concentrations of HDL-C, and more negative K-values (Table 1) .
Oxidation Characteristics of LDL and LDL Antioxidant Contents
The mean lag time of LDL for oxidation was shorter in group 3 than in group 1 (Tukey, PC.05) ( Table 2 ). In group 2, an intermediate mean lag time was measured which, probably due to the small group size, did not differ significantly from both other groups. When we considered groups 2 and 3 as one group, on the basis of characteriza tion of the LDL subfraction profile, we observed that the mean lag time of LDL to oxidation was shorter than that in group 1 ( Table 3 ). Exclusion of the smokers in the re spective groups did not affect the presented results. The lag time of total LDL to oxidation correlated with the den sity of the LDL subfraction profile of the subjects, ex pressed as the continuous variable K (r=.35, PC.05). The maximal amount of dienes formed per milligram of LDL protein during oxidation of LDL isolated from FCH sub jects was lower than the amount of dienes formed in LDL from group 1. Oxidation rates of LDL and basal amounts of dienes in LDL were similar in the three groups.
We examined whether the oxidation characteristics of LDL could be attributed to differences in the basal a-TOH and QftU-lO concentrations. Plasma concentrations of QI-I2-10 were related to plasma concentrations of total cho lesterol (r=.41, PC.01) and a-TOH (r=.41, PC.01). The absolute and relative concentrations of a-TOH, QI-L-IO, and Q10 in plasma and LDL are given in Table 4 , while the most important results are presented in the Figure. No differences were found between the three groups in the LDL a-TOH content, quantified relatively to cholesterol, apolipoprotein, or PUFA (Table 4 ). While the LDL QH2-10 content, relatively to apolipoprotein and PUFA, tended to be lower in group 2 than group 1 (Tukey, P -.07), the Q10 content was significantly increased (Ta  ble 4 ). The fatty acid composition of LDL was similar in all three groups (Table 4 ). Remarkably, for all subjects with a dense LDL subfraction profile, both the ratio of LDL QHa-10 to a-TOH and the redox status of coenzyme Q10 in LDL (QH2-10/Q10 ratio) were lower than the ratios in LDL from subjects having a buoyant LDL subfraction profile (Figure) . In line with this, the redox status of co enzyme Q10 correlated with the density of the LDL sub fraction profile (;*=.37, P<.05). In nonsmoking subjects the ratio of LDL QH2-10 to a-TOH was 0.05±0.01, 0.03±0.01 (PC.05 versus group 1), and 0.04±0.01 for groups 1, 2, and 3, respectively. Furthermore, exclusion of the smokers in the three groups resulted in a redox status of coenzyme Q10 in LDL of 3.4±1.0, 1.5± 1.5 (PC.05 versus group I), and 2.1 ±0.8 (Pc.005 versus group 1), respectively. Even when groups 2 and 3 are considered as one group, characterized by a dense LDL subfraction pro file (n=23), both ratios were significantly lower than those in group 1 ( Table 4 ). Regarding our stability experiments (see "Methods" ), it is unlikely that the observed differ ences in the ratios were due to oxidation ex vivo. A second indication that the shift in the redox status of coenzyme Q10 was not an artifact appeared in the similarity of the redox ratios in total plasma versus the indicated LDL frac tion in the various groups.
In the combined groups, we observed that 53% of the variability in oxidation rate could be predicted by the basal amount of dienes in LDL together with the basal LDL QH2-10 to LDL PUFA content ratio (Pc.OOOl).
Discussion
Total LDL in FCH subjects (group 3) was less well pro tected against copper-mediated oxidation than total LDL from normolipidemic relatives with a buoyant LDL sub fraction profile (group 1). Even when the subjects of groups 2 and 3, all characterized by a dense LDL subfrac tion profile, were combined, their LDL was more prone to oxidation than the LDL of group 1 (P<.05). To our knowl edge, this is the first time a reduced oxidation resistance of total LDL, instead of isolated LDL subfractions, is pre sented for subjects characterized by a dense LDL subfrac tion profile. Possibly, the conformation of dense LDL par ticles facilitates the of to *LDL isolated from group 1 subjects; tLDL isolated from group 2 and 3 subjects. t.0005<P<.005; §.01<P<.05.
apolipoprotein B100, or the premature exhaustion of an tioxidants, thereby explaining the increased susceptibility to oxidation.-19
Quantitatively, a-TOH is an important antioxidant in LDL.20 However, in line with observations of other groups with subjects on a normal diet, the susceptibility of LDL to oxidative modification was not related to the a-TOH content of LDL. -14'40-43 From in vitro oxidation studies, QH2-IO is shown to be an antioxidant of the first line.26 LDL that was isolated from normolipidemic subjects with dense LDL tended to have a lower QH2-10 content, rela tive to the apolipoprotein B100 01* PUFA contents, than LDL from subjects with a buoyant profile. In addition, the redox status of coenzyme QIO (ratio of reduced form to oxidized form of coenzyme QIO) was substantially re duced in dense LDL particles, independent of whether LDL was isolated from normolipidemic or hyperlipidemie subjects (Figure) . The oxidation of QI-L-10 within LDL particles was reported to be accompanied by the formation of lipid hydroperoxides within LDL.-1 ' Our data on the redox status of coenzyme QI O and the consequences con cerning the initial degree of lipid peroxidation concur with data of Alieva et al. 44 For normolipidemic subjects these authors showed that hydroperoxide concentrations were increased in dense LDL compared with buoyant LDL par ticles. An increased lipid hydroperoxide content in dense LDL may also explain the observed increased susceptibil ity of dense LDL to copper-mediated oxidation in vitro.4S In healthy subjects, elevated concentrations of plasma lipid hydroperoxides were measured, in vivo, when the redox status of coenzyme QIO was reduced.46 Thus, the redox status of coenzyme QIO in dense LDL appears to be a sensitive marker for oxidative changes that take place in LDL in vivo. By careful analysis, we have shown that the reduced redox status of coenzyme QIO in groups 2 and 3, versus that in group 1, cannot be explained by a higher artificial oxidation of QH2-10 during the several analysis steps. In this respect it is interesting to note the 3-to 30fold-lower QH2-10 concentration in LDL of normolipid emic subjects™ compared with concentrations measured in other studies2i'-27 and in the present study. We ascribe this to the lengthy isolation procedure of 3 days, including the dialysis step. To prevent loss or oxidation of LDL QH2- Relative QH2-10 concentrations in LDL. LDL QHa-10 content was quantified relative to the o-TOH content (lefty axis, hatched bars), and the Q-10 content (redox status) (right y axis, filled bars). Group 1 indicates normolipidemic subjects with a buoyant LDL subtraction profile (n=12); Group 2, normolipidemic subjects with a dense profile (n=7); and Group 3, FCH subjects with a dense profile (n=16). *P < .05 vs group 1.
10, LDL was not dialyzed in our study. This may explain why we did not find any relation between lag time and QH2-10 content. In agreement with Kontush et al, 47 we found that the basal LDL QI-L-10 to PUFA content ratio « M was negatively correlated with the rate of oxidative mod ification of LDL. QH2-I0 may indirectly protect the PUFAs against lipid peroxidation by efficient reduction of a-TOH radicals (reviewed in Reference 23). In line with results of Stocker and coworkers,26-27 our results stress the promising role of QH2-I0.
Whether a decrease in the redox status of coenzyme QIO in LDL, due to oxidation of QH2-10, results in minimally oxidized LDL needs to be studied. Compared with native LDL, mildly oxidized LDL exerts important biological ef fects, at least in vitro. It is believed that these are involved in the early stages of atherosclerosis.4H Minimally oxidized LDL was shown to stimulate the endothelial cell-mediated attractant protein4 1 1 and mono-• hand, it may be possible that the radicals that result in oxidation of co enzyme QIO can also induce tryptophan residue destruc- tion.51 This process occurs in two phases; the earliest phase is independent of a'-TOH and plays an initial role in LDL lipid peroxidation. 51 In conclusion, dense LDL particles from subjects with FCH are less resistant to oxidation in vitro than buoyant LDL from normolipidemic relatives. Compared with sub jects with an overall buoyant LDL subfraction profile, the redox status of coenzyme QIO was reduced in subjects with an overall dense LDL subfraction profile, indepen dent of the plasma concentration of cholesterol or triglyc erides* This suggests that QH2-10 is an important indicator of oxidative modification in vivo. Future investigations to assess oxidative stress in subjects at risk for coronary heart disease should include the redox status of coenzyme QIO.
